An Investigator initiated study comparing of two antifungals Anidulafungin and Caspofungin in patients with Invasive Candida Infections
Not Applicable
- Conditions
- Health Condition 1: B377- Candidal sepsis
- Registration Number
- CTRI/2021/09/037013
- Lead Sponsor
- Dr Yatin Mehta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of either sex with age =18 years with a confirmed cases of Invasive Candida infection.
2. Patients who will be able to provide the informed consent.
3. Patients prescribed with Caspofungin or Anidulafungin
Exclusion Criteria
1. Patients of either sex with age less than 18 years.
2. Patients with aspergillus or any other mold or yeast [Cryptococcus] infections.
3. Patients on Micafungin or other antifungal agents.
4. Pregnant or breast-feeding women
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method